Summit Therapeutics, Inc.
Director, Clinical Operations EU & Partner Liaison
11 days ago
Abingdon
Join to apply for the Director, Clinical Operations EU & Partner Liaison role at Summit Therapeutics, Inc. Ivonescimab, known as SMT112, is a novel, potential first-in-class investigational bispecific antibody combining immunotherapy via PD-1 blockade with anti-angiogenesis effects by blocking ...